Fundraising FoxAtransen Pharma株式会社
Osaka, JP · 1 known investors
Find your way into Atransen Pharma株式会社
Sign up to see every warm intro you have to Atransen Pharma株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Atransen Pharma株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atransen Pharma is a biotech company developing novel cancer treatments through LAT1 inhibitors and transporter-based drug discovery approaches. The company's research builds on amino acid transporter science from Osaka University and aims to create more effective cancer therapies with fewer side effects.
Founders & leadership
TA
Tomoyuki AsanoRepresentative Director & CEO
Investors · 1
Frequently asked questions
- What does Atransen Pharma株式会社 do?
- Atransen Pharma is a biotech company developing novel cancer treatments through LAT1 inhibitors and transporter-based drug discovery approaches. The company's research builds on amino acid transporter science from Osaka University and aims to create more effective cancer therapies with fewer side effects.
- Who are Atransen Pharma株式会社's investors?
- Atransen Pharma株式会社's investors include Angel Bridge Co.,Ltd..
- Where is Atransen Pharma株式会社 headquartered?
- Atransen Pharma株式会社 is headquartered in Osaka, JP.